Stay updated with breaking news from Chris Benko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Most Alzheimer's drug trials are using paper measurement tools developed in the 1980's and 1990's. Neurotechnology can do better for patients, while saving us billions.
The digital biomarkers company has partnered with Beacon Biosignlas, a computational neurodiagnostics company to launch a clinical trial investigate the integration of Beacon’s at-home electroencephalogram (EEG) into Koneksa’s neuroscience solution toolkit.
The digital biomarkers company has partnered with Beacon Biosignlas, a computational neurodiagnostics company to launch a clinical trial investigate the integration of Beacon’s at-home electroencephalogram (EEG) into Koneska’s neuroscience solution toolkit.
The study aims to discover biomarkers and determine the usability of measures of sleep disorders collected using at-home EEG.
Chris Benko, CPA Crain's Cleveland Notable Leaders in Accounting and ConsultingCrain's Cleveland Notable Leaders i...